Evaluating the Role of Cytology in Monitoring and Assessing Treatment Response in Hematological Malignancies: A Prospective Study

Background: Hematological malignancies, encompassing a spectrum of diseases such as leukemia, lymphoma, and multiple myeloma, pose significant clinical challenges due to their heterogeneity and complex treatment regimens. Precise monitoring of treatment response is paramount for optimizing therapeutic strategies and improving patient outcomes. Objective: This prospective study aims to evaluate the efficacy of cytology as a tool for monitoring treatment response in patients with hematological malignancies. By comparing cytology with established diagnostic modalities like flow cytometry and molecular testing, the study seeks to determine its sensitivity, specificity, and correlation with clinical outcomes. Methods: Over a 12-months period, 150 patients diagnosed with acute leukemia, lymphoma, or multiple myeloma were enrolled. Cytological analyses were performed at baseline, mid-treatment, and post-treatment phases. Data on clinical outcomes were collected and correlated with cytological findings. Statistical measures, including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), were computed, and Kaplan-Meier survival analyses were conducted. Results: Cytology demonstrated a sensitivity of 85% and specificity of 90% in detecting treatment-induced cellular changes. A strong correlation was observed between cytological findings and clinical outcomes, particularly in patients achieving complete or partial responses. While cytology was effective in monitoring gross morphological changes, its capability to detect minimal residual disease (MRD) was limited compared to flow cytometry and molecular testing. Conclusion: Cytology emerges as a valuable, cost-effective tool for monitoring treatment response in hematological malignancies, especially in resource-constrained settings. However, its limitations in MRD detection underscore the need for its integration with more advanced diagnostic modalities to ensure comprehensive patient assessment.